A putative role for Spry4 as part of Wnt7A/Fzd9 tumor-suppressing pathway was initially suggested by Winn et al., where Wnt7A and Fzd9 induced the expression of Spry4 in NSCLC cells [136]. Here, FZD9 is linked to non-small cell lung carcinoma.